Podcasts about cancer surgery

This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This second episode highlights the thyroid cancer operative standard.Hosts:Tracy Wang, MD, MPH, FACS is a Professor of Surgery and Vice-Chair of Strategic and Professional Development at the Medical College of Wisconsin with a clinical focus on endocrine surgical oncology. Vladmir Neychev, MD, PhD is a Professor of Surgery at the University of Central Florida College of Medicine with a clinical focus on endocrine surgical oncology.Jack Sample, MD (@JackWSample) is a General Surgery Resident at Mayo Clinic Rochester.Guests:Elizabeth Grubbs, MD (@EGrubbsMD) is a Professor of Surgical Oncology at MD Anderson where she specializes in endocrine tumors, with expertise in cancer of the thyroid.David Hughes, MD is a Clinical Associate Professor of Surgery at University of Michigan, where he focuses on surgical diseases of the endocrine system, including a particular focus on the diagnosis and management of papillary thyroid cancer.Learning Objectives: Understand key preoperative and intraoperative aspects of the evaluation and treatment of patients with biopsy-proven papillary thyroid carcinoma (PTC) greater than or equal to 1 cm. Define factors that guide decision making regarding the extent of surgical resection (lobectomy versus total thyroidectomy) for PTC.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 2: Thyroid, Gastric, Rectum, Esophagus, Melanomahttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:Amazon.com: Operative Standards for Cancer Surgery: Volume 2, Section 1: Thyroid eBook : Program, American College of Surgeons Clinical Research, Katz, Matthew HG: Kindle StoreImpact of Extent of Surgery on Survival for Papillary Thyroid Cancer Patients Younger Than 45 years. https://pubmed.ncbi.nlm.nih.gov/25337927/ Extent of Surgery Affects Survival for Papillary Thyroid Cancer. https://pubmed.ncbi.nlm.nih.gov/17717441/Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this episode of SurgOnc Today, Casey Allen leads a discussion with Oluwadamilola Fayanju, Laura Dominici, Michael Egger, Cristina O'Donoghue, and Winta Mehtsun, exploring how value-based care principles intersect with access, equity, and health policy in surgical oncology. The conversation highlights social determinants of health, rural outreach, and global initiatives advancing high-quality, value-based cancer surgery.

Moderator: James P. Rathmell, M.D. Participants: Elliott Bennett-Guerrero, M.D. and Juan P. Cata, M.D. Articles Discussed: Anesthesia Type During Cancer Surgery: Results of the GA-CARES Randomized, Multicenter Trial Volatile General Anesthetics and Oncologic Surgery: A Safe Choice

Excision is routine work in primary care, but deciding who should wield the scalpel isn't always straightforward. In this episode of Life by A Thousand Cuts, A/Prof Tony Dicker explores the real-world judgement calls GPs make every day: when a skin cancer can be safely managed in-house, and when referral is the wiser path. Tune into the episode below to hear a grounded, experience-based discussion covering: Why local anaesthetic tolerance remains a key early filter. How size, complexity and your own comfort level influence the decision to proceed. The value of working alongside more experienced colleagues, and why observing can still be a worthwhile investment in your skills. When patient preference, social factors, and after-care logistics should tip the balance toward referral. Why a transparent, informed-consent conversation protects both patient outcomes and your medico-legal footing. This week's episode is a concise, candid look at the grey zones of primary-care skin cancer surgery, ideal for any GP refining their procedural decision-making.   Prefer a visual format? Watch this podcast here. Life by a Thousand Cuts  This podcast series is designed to help you enhance your clinical decision-making, procedural skills, and confidence in skin cancer management. Focus on real-world cases, surgical techniques and tips, journal article reviews, diagnostic and management insights, and guest interviews with GPs and specialists. Next steps in your learning journey

In this episode, Gregory J. Tiesi, MD, FACS, FSSO, hosted a discussion about innovations in regional cancer therapies. Dr Tiesi is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Jersey Shore University Medical Center in Toms River and Brick, New Jersey. He was joined by: Anthony Scholer, MD, FACS, FSSO, a surgical oncologist specializing in hepatobiliary surgery, at Hackensack Meridian Medical Group and Jersey Shore University Medical Center in Neptune, New Jersey Benjamin Jon Golas, MD, FACS, regional chief of Surgical Oncology for Hackensack Meridian Health's Central Region, surgical director of Oncology Services at Jersey Shore University Medical Center, vice chair of Surgery at Jersey Shore University Medical Center Cancer Surgery, and an associate professor of surgery at the Hackensack Meridian School of Medicine in Neptune and Edison, New Jersey Eric Pletcher, MD, a surgeon specializing in Complex General Surgical Oncology at Hackensack Meridian JFK University Medical Center in Edison Drs Tiesi, Scholer, Golas, and Pletcher chatted about the use of pressurized intraperitoneal aerosolized chemotherapy (PIPAC), a minimally invasive regional cancer therapy designed for patients with peritoneal metastases or primary peritoneal cancers. The experts explained that this laparoscopic approach overcomes several limitations of traditional systemic treatments by delivering aerosolized chemotherapy in fine droplets under high pressure into the peritoneal cavity. This process ensures uniform drug distribution and enhanced tissue penetration, allowing for efficacy with lower systemic drug concentrations, they noted.  PIPAC candidates typically present with unresectable or recurrent disease, or symptomatic malignant ascites, and should have an ECOG performance status between 0 and 2, they elaborated. The procedure, which is repeatable every 4 to 6 weeks, includes diagnostic laparoscopy, quantification of the peritoneal carcinomatosis index, and serial biopsies to assess treatment response. They emphasized that PIPAC has a favorable safety profile, with low 30-day mortality rates and minimal grade 3/4 adverse effects reported in clinical trials. Additionally, they stated that clinical data indicate high pathologic response rates and the potential for disease downstaging, enabling some patients who were initially deemed unresectable to become eligible for subsequent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Of note, the experts reported that PIPAC is designed to be integrated seamlessly with concurrent systemic therapy.

Evolution of Cancer Surgery: How Far Have We Come? with guest Dr. Kevin Billingsley November 30, 2025 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Local anaesthetic choice and dosing are such a routine part of skin cancer surgery that it's easy to fall into habit. But with ongoing supply pressures, evolving research, and the increasing volume of procedures performed in primary care, many GPs are now asking: how low can we safely go with lignocaine concentrations, and does dilution actually work? In this episode of Life by A Thousand Cuts, A/Prof Tony Dicker breaks down the evidence on lignocaine dosing, including what the newer data tells us about using lower concentrations in day-to-day skin cancer work. This episode covers: Why names like lignocaine, lidocaine, Xylocaine, adrenaline, and epinephrine all trace back to the same core agents. How standard concentrations (1% and 2%, with or without adrenaline) compare with the diluted formulations used in dermatologic surgery. What the January 2025 Dermatologic Surgery double-blind trial found when comparing 0.25% vs 0.5% lignocaine, and why both were equally effective for pain control, patient satisfaction, and top-ups. How these findings relate to tumescent anaesthesia in liposuction, where even more dilute solutions still perform reliably. Practical safety limits, including the importance of avoiding unnecessarily large volumes in primary care and maintaining robust processes if your clinic is diluting local anaesthetic. Real-world considerations around toxicity, duration of effect, and past adverse events that underline why careful dosing still matters. If you perform skin cancer procedures in general practice, this is a crisp, evidence-focused update on a tool you use every day, with some simple takeaways you can apply immediately.   Prefer a visual format? Watch this podcast here. Life by a Thousand Cuts  This podcast series is designed to help you enhance your clinical decision-making, procedural skills, and confidence in skin cancer management. Focus on real-world cases, surgical techniques and tips, journal article reviews, diagnostic and management insights, and guest interviews with GPs and specialists. Next steps in your learning journey

Pippa Hudson speaks to physiotherapist Cheryl Gaynor about the risk of a condition called cording which may develop after breast cancer surgery. Lunch with Pippa Hudson is CapeTalk’s mid-afternoon show. This 2-hour respite from hard news encourages the audience to take the time to explore, taste, read, and reflect. The show - presented by former journalist, baker and water sports enthusiast Pippa Hudson - is unashamedly lifestyle driven. Popular features include a daily profile interview #OnTheCouch at 1:10 pm. Consumer issues are in the spotlight every Wednesday while the team also unpacks all things related to health, wealth & the environment. Thank you for listening to a podcast from Lunch with Pippa Hudson Listen live on Primedia+ weekdays between 13:00 and 15:00 (SA Time) to Lunch with Pippa Hudson broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/MdSlWEs or find all the catch-up podcasts here https://buff.ly/fDJWe69 Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This first episode highlights the colon cancer operative standard. Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology fellow at MD Anderson Cancer Center. Guest: George Chang, MD, MS, MHCM, FACS, FASCRS, FSSO is a Professor and the interim Department Chair in the Department of Colon and Rectal Surgery at MD Anderson Cancer Center.   Learning Objectives: The extent of colon mobilization and resection depends on tumor location, with high vascular ligation of the tumor-bearing segment to complete adequate regional lymphadenectomy. The technical steps of right colectomy are reviewed, including high ligation of the ileocolic pedicle at the level of the superior mesenteric vein, and the right branch of the middle colic artery if present. Tips and tricks are discussed to identify vascular structures and avoid central vascular injury. Links to Papers Referenced in this Episode Operative Standards for Cancer Surgery, Volume 1: Breast, Lung, Pancreas, Colon https://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/ Kindle edition: https://www.amazon.com/Operative-Standards-Cancer-Surgery-Section-ebook/dp/B07MWSNFSB Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomized, controlled, phase 3, superiority trial Lancet Oncol. 2021 Mar; 22(3):391-401. https://pubmed.ncbi.nlm.nih.gov/33587893/ Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer. Ann Surg Oncol. 2018 Jan;25(1):38-45. https://pubmed.ncbi.nlm.nih.gov/27942902/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

New options for knee pain—radiation and embolization; Popeye was right to power-up with spinach; Conquering inflammation; Methane-predominant SIBO; Unnecessary back surgery on seniors is rampant; Medicare Advantage patients often relegated to inferior cancer surgery. 

BUFFALO, NY – October 20, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on October 16, 2025, titled “Widespread folate receptor expression in pediatric and adolescent solid tumors – opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine.” In this study, led by first author Ashley C. Dodd from Ann & Robert H. Lurie Children's Hospital and corresponding author Timothy B. Lautz from the same institution and Northwestern University Feinberg School of Medicine, researchers discovered that folate receptor beta (FRβ) is widely expressed in various pediatric and adolescent solid tumors. This finding highlights FRβ as a promising target for improving the accuracy of tumor surgery using a fluorescent imaging agent known as pafolacianine. Pediatric cancers are often challenging to remove completely during surgery, particularly when tumors spread or form small metastases. Fluorescence-guided surgery is a method that helps surgeons better identify tumors during operations using special imaging dyes. However, commonly used dyes such as indocyanine green are not tumor-specific and rely on general features of blood vessel permeability, limiting their precision. In this study, researchers investigated the potential of pafolacianine, a next-generation dye that targets folate receptors, for pediatric use. Folate receptors are proteins commonly found on the surface of cancer cells. Pafolacianine is already FDA-approved for adults with ovarian and lung cancers due to its ability to bind these receptors and highlight tumors during surgery. The research team analyzed tissue samples from 13 young patients diagnosed with various cancers, including Wilms tumor, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, Ewing sarcoma, and neuroblastoma. The results showed that FRα was predominantly absent, whereas FRβ was present in 100% of the tumor samples. Notably, FRβ appeared both on the tumor cells and in the surrounding tumor microenvironment but showed little to no expression in normal tissue, making it an excellent candidate for targeted imaging. “In this study, we performed immunohistochemistry staining on slides obtained from a range of pediatric patients with solid tumors.” This consistent expression of FRβ in pediatric tumors is a significant and novel finding. Earlier studies primarily linked FRβ to immune cells called tumor-associated macrophages. This study reveals that FRβ is also expressed directly on tumor tissue, which could help surgeons better distinguish cancer from healthy tissue during procedures. Based on these results, the team has launched a clinical trial to evaluate pafolacianine in children undergoing surgery for metastatic lung tumors. If successful, this method could make pediatric cancer surgery safer and more effective. Overall, this study suggests that targeting FRβ with pafolacianine could serve as a tumor-agnostic imaging strategy, applicable across a wide range of pediatric solid tumors. This represents a potential advancement in real-time surgical imaging and a step forward in pediatric cancer care. DOI - https://doi.org/10.18632/oncotarget.28772 Correspondence to - Timothy B. Lautz - TLautz@luriechildrens.org Abstract video - https://www.youtube.com/watch?v=0its0QkOcwM Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Chi Fu Jeffrey Yang. MD, Thoracic surgeon at Massachusetts General Hospital, Professor of surgery at Harvard Medical School For any cancer patient facing surgery, there are always questions and worries. Hildy interviews an outstanding thoracic surgeon at Massachusetts General Hospital, Chi Fu Jeffrey yang, MD. They discuss the … Continue reading CUT IT OUT! What To Know About Lung Cancer Surgery →

Love the episode? Send us a text!In this episode of Breast Cancer Conversations, host Laura Carfang sits down with Dr. Evan Garfein, Chief of Plastic Surgery at Montefiore Medical Center, Professor of Surgery at Albert Einstein College of Medicine, and Co-Founder of Greenwich Street Aesthetics. With more than 60 peer-reviewed publications, three biomedical patents, and a leadership role in shaping New York State's groundbreaking breast reconstruction equity law, Dr. Garfein brings unmatched insight into the intersection of medicine, policy, and patient empowerment.Together, Laura and Dr. Garfein unpack:How breast reconstruction has evolved—and where the field is headedWhat patients need to know about their rights, options, and insurance coverageThe real-world impact of legislation that expands access and equity in reconstructive careThe latest innovations in surgical techniques and materials that are reshaping outcomesThe emotional and psychological dimensions of reconstruction and recoveryWhether you're a patient, caregiver, or clinician, this conversation offers valuable guidance on making informed decisions and navigating the post-mastectomy journey with confidence.Attend a free virtual SurvivingBreastCancer.org program (support groups, yoga, medication, expressive writing, art expression, and more!):https://www.survivingbreastcancer.org/eventsSubscribe to our weekly newsletterhttps://www.survivingbreastcancer.org/subscribeFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/Support our Podcast, every dollar counts!https://givebutter.com/0fCiEUSupport the showLatest News: Join our Tell Cancer To Go #TakeAHike October 25, 2025 fundraiser! It's free to sign up! Learn more and start your team! Become a Breast Cancer Conversations+ Member! Sign Up Now.

In this episode of Life by A Thousand Cuts podcast, A/Prof Tony Dicker explores a critical topic for doctors surgically treating skin cancers: how to avoid accidentally cutting nerves during procedures. A/Prof Dicker offers real-world strategies to help you plan safer surgeries. The discussion covers several major nerves relevant to skin cancer surgery, particularly in the head and neck region: Accessory nerve – Damage here can cause significant morbidity, including shoulder weakness and difficulty raising the arm. A/Prof Dicker explains how to identify its path along the sternocleidomastoid and when referral is the safer option. Temporal branch of the facial nerve – Injury can cause unwanted, asymmetric paralysis of the forehead. A/Prof Dicker shares a simple anatomical landmark and tips for safer anaesthesia. Marginal mandibular branch of the facial nerve – Though variable in its course, awareness of its position along the jawline can help avoid serious complications. Common peroneal nerve – In the lower limb, damage can lead to foot drop, a complication with major functional consequences. A/Prof Dicker also highlights commonly overlooked issues such as forehead numbness from small sensory nerves, why tumescent anaesthesia can improve safety in thin-skinned patients, and the importance of patient communication before surgery to manage expectations and reduce distress. This episode is packed with practical pearls for clinicians working in skin cancer surgery, reminding us that while excision margins and pathology are essential, so too is thoughtful consideration of what lies beneath.   Watch this episode here. Life by a Thousand Cuts  This podcast series is designed to help you enhance your clinical decision-making, procedural skills, and confidence in skin cancer management. Focus on real-world cases, surgical techniques and tips, journal article reviews, diagnostic and management insights, and guest interviews with GPs and specialists. Next steps in your learning journey

In this episode of Life by A Thousand Cuts, A/Prof Tony Dicker takes a closer look at surgical marking pens, exploring how the simple act of drawing a line can influence outcomes. Anyone who has carefully mapped a surgical plan only to see it vanish after prepping the skin, knows the frustration. In this podcast, A/Prof Dicker dives into the evidence behind different pens, from gentian violet markers to permanent markers and even the humble biro, and how antiseptic agents like chlorhexidine, Betadine, and alcohol impact their durability. He also delves into infection risk, cross-contamination, and the rare but real possibility of ink tattooing if markings are incised. Studies comparing pen performance across skin types and prep solutions offer valuable insights. A/Prof Dicker also shares his own preferences: permanent markers with a mid-sized tip for clear, reliable lines, applied after cleaning intact skin with alcohol wipes. He stresses the importance of tailoring pen choice to both the surgical setting and patient factors, especially skin tone. Watch this episode here. Life by a Thousand Cuts  This podcast series is designed to help you enhance your clinical decision-making, procedural skills, and confidence in skin cancer management. Focus on real-world cases, surgical techniques and tips, journal article reviews, diagnostic and management insights, and guest interviews with GPs and specialists. Next steps in your learning journey

In this episode of the "Southern Medicine Podcast," J. Quincy Brown, PhD, and Randy Glick, BSB/PM, MCP discuss the state of the art in next-generation surgical pathology imaging methods for fresh-tissue histology, as well as the need and requirements for intraoperative tumor margin imaging systems. Another topic detailed is the integration of imaging hardware and AI for clinical decision making. Dr. J. Quincy Brown is a Professor of Biomedical Engineering at Tulane University and is a biomedical engineer whose career has been focused on the development and translation of light-based sensing and imaging technologies in medicine. Recently, he and his team were selected as an awardee of the Advanced Research Projects Agency for Health (ARPA-H) Precision Surgical Interventions program. The project, called MAGIC-SCAN, is seeking to develop an end-to-end, human + AI collaborative rapid microscopic scanner for comprehensive pathologic imaging of resected tumors in the operating room. 

In this episode of The Cancer Assist Podcast, Dr. Bill Evans speaks with Dr. Christopher Coroneos, Associate Professor at McMaster University and reconstructive surgeon at the Juravinski Cancer Centre. Together, they explore the evolving world of breast reconstruction from immediate and delayed procedures to oncoplastic surgery, nipple-sparing techniques, and the use of a patient's own tissue versus implants. Dr. Coroneos also addresses topics like breast implant safety, breast implant illness, risks, while offering insight into complex reconstructive procedures beyond breast surgery, including limb salvage.

What if artificial intelligence could help save your erections during prostate cancer surgery?In this groundbreaking episode of the Dr. Geo Prostate Podcast, Dr. Geo sits down with world-renowned urologist and sexual health pioneer Dr. Arthur "Bud" Burnett from Johns Hopkins. Together, they discuss an exciting new frontier in men's health: using AI and intraoperative neuromonitoring to preserve erectile function during prostate cancer surgery.Dr. Burnett shares his four decades of experience and explains how advanced techniques — including real-time nerve mapping and AI-guided signals during surgery — are transforming outcomes for men. Imagine a future where surgeons can “see” and protect the exact nerves critical for erections, like having a GPS guiding them in real time.They also dive into:✅ The evolution of erectile dysfunction treatments — from Yohimbine to Viagra and beyond✅ The history and future of penile implants, including the possibility of app-controlled devices✅ Why nerve-sparing techniques alone may not be enough to preserve function after prostatectomy✅ How AI and precision medicine are changing surgical outcomes and offering men more hopePlus, Dr. Burnett discusses upcoming clinical trials and how men can potentially participate today at Johns Hopkins.

There are new realizations all the time in this breast cancer life experience. I recently realized I need to preserve the veins in my arm not affected by breast cancer surgery. I have been mindful about not getting any injections, blood draws or bug bites on my left arm since I had my mastectomy and sentinel lymph node dissection 2 years ago. Recently I realized that preserving the veins in my right arm is something to be mindful about.  I have had a few blood draws over the past year. These are generally drawn from the same place in my right arm, at the bend of the elbow. The phlebotomists are always good at hitting the vein on the first attempt, which I appreciate greatly. However, I recently thought about the effect of consistently having blood drawn in the same place. There could be scarring there. I realize it is possible that in the future, I could need IVs or other labs that are done at the same place. I need to preserve the veins on my unaffected side.  If it were not for breast cancer, this would not be an issue. This is another reason I make this podcast - to share the experience of all that encompasses this life.  If you'd like to be the first to receive updates and exclusive content from the upcoming Breast Cancer Life newsletter, please email me at connect@breastcancerlife.org. I'd love to have you on the list! LET'S CONNECT: connect@breastcancerlife.org  Follow us on Pinterest 

I'm pulling back the curtain and sharing my own cancer surgery recovery playbook—my 5 rapid recovery tools that helped me bounce back faster than my doctor thought possible. You'll get the real story about my hysterectomy, the emotional rollercoaster of a cancer diagnosis (yep, I'm officially cancer-free!), and the exact science-backed strategies I used to speed heal, crush inflammation, support my immune system, and get back to the gym way ahead of schedule. If cancer, surgery, or just flat-out “I need to heal now” vibes are on your radar, this is the badass protocol you've been waiting for. Trust me, you don't want to miss this one. I break down my top tools—from black cumin seed oil (a total inflammation-buster and cancer-fighting powerhouse), to red light therapy, to grounding with the Aligned Mat, optimizing hormone health with my go-to supplement, and of course, strategic use of cutting-edge peptides. Whether you're facing a tough diagnosis or just want to bulletproof your body, these tactics aren't just for post-op—they're for life and prevention, too. Listen in to get the actionable steps, the “why” behind each one, and your first-class ticket to never hearing that C word. Prevention, healing, and next-level thriving—all inside this episode! Dr. Amie's Healing Protocol: https://health.dramie.com/healing-protocol WHAT DO MY LABS MEAN?! Try the ultimate tool to Decode Your Labs: Understand your thyroid, hormones, and blood sugar numbers to transform your health https://dramie.com/labs/ We prescribe to all 50 states!  When you're ready to FINALLY get the help you deserve… Book a free application call: https://dramie.com/book-a-call/ Shop ALL of Dr. Amie's Fixxr® Supplements: https://betterlifedoctor.com/ EARN CE Credits: "Nurses, hold-on  – here comes the exciting part: you can earn nursing CE credits by listening to our podcasts! That's right—RNegade has teamed up with podcast hosts like me who are delivering amazing content that doesn't limit you to “thinking outside-the box,” it challenges you to BLOW-UP the box by learning from innovators, pioneers, and RENEGADES in the field of health and medicine WHILE EARNING YOUR CEs!” https://rnegade.thinkific.com/?ref=4d98d0 RATE, REVIEW AND FOLLOW ON APPLE PODCASTS If you made it this far I'm impressed! That means you really love the show and I love you for that!  So I'm going to ask you for a favor. Would you please leave a quick review or even 5⭐️. I DO read them and can't tell you how much I appreciate it! Thank you in advance!❤️  Just click here it's quick and easy : https://podcasts.apple.com/us/podcast/the-thyroid-fixer/id1529800263,  Ok ONE MORE favor…would you please subscribe and follow the show? This is a win-win! It tells the podcast powers that be that you like The Thyroid Fixer Podcast AND it lets you catch all the new episodes that come out every week. Follow with this link: https://podcasts.apple.com/us/podcast/the-thyroid-fixer/id1529800263 and never miss out on a moment of the journey! CONNECT WITH ME ON SOCIAL MEDIA: Want to get your labs reviewed and your questions answered LIVE by me? Join my exclusive Facebook group, Just Fix Your Thyroid – a supportive and empowering community designed to give you the tools, guidance, and HOPE you need on your thyroid and hormone journey.

Melvin J. Silverstein, now Medical Director of Hoag Breast Center and the Gross Family Foundation Endowed Chair in Oncoplastic Breast Surgery at USC, sat down with Stacy Wentworth, radiation oncologist and medical historian, to reflect on his career.Silverstein founded the Van Nuys Breast Center in 1979. As he saw more and more and more patients with what was only recently coming to be known as ductal carcinoma in situ (DCIS), he wrote the first major textbook on the disease and developed the Van Nuys Classification for Ductal Carcinoma in Situ of the Breast as well as the USC Van Nuys Prognostic Index.Wentworth asked Silverstein about a time when his science was challenged by the medical establishment. At the time, most surgeons favored treating DCIS just like aggressive, invasive breast cancers, with mastectomy and radiation.Silverstein wasn't so sure about that. He felt that, in some cases, radiation wasn't necessary.Silverstein debated against radiation oncologists at conferences for years, and his arguments stirred up visceral responses, he recalls.“Pro-radiation therapy were all the radiation oncologists from academic centers. That was Jay Harris, who was I guess my arch rival in this. He once, after one of these talks, came up to me, smiled at me and said, ‘You're killing patients.' Which broke my heart,” Silverstein said. “It was a terrible thing. He said to me after not giving radiation therapy, but it turns out in the long run, everybody's come on board. And clearly now it's 25, 30 years later, some people have finally agreed that they all don't need it.”Recent trial results have confirmed Silverstein's analysis that not all patients with DCIS need radiation.Today, Silverstein runs the USC breast fellowship program, which has an emphasis on oncoplastic surgery—the first of its kind.Read more at https://cancerhistoryproject.com/article/melvin-silverstein/

Learn how your treatment plan is decided and terms you may seeWe continue our series to help you understand cancer and its treatment. This week we focus on surgery, the oldest form of cancer treatment. Learn about surgery timing, types of cancer surgery, and how NCCN evidence-based guidelines provide a standard treatment path no matter where you are.In this Episode:02:58 - Wisconsin-Cheese, UFOs, and Booyah Stew04:52 - Anna Quindlen: Get a Life Where You Are Generous"08:06 - Medical Specialists Involved in Cancer Care08:52 - Treatment Decisions, Tumor Board and NCCN Guidelines12:03 - Adjuvant and Neoadjuvant Therapy13:13 - Surgery Timing, Reasons and Types18:00 - Discussion - NCCN and Role of Research24:34 - Reeves Keyworth:“On Loved Ones Telling the Dying to ‘Let Go”23:54 - OutroSurgery, radiation therapy, and chemotherapy alone or in combination are the most-common methods used to treat cancer. Specific treatment varies depending on the kind of cancer, the extent of the disease, its rate of progression, and the condition of the person. Surgery alone may not result in a cure and often chemotherapy and/or radiation are needed after surgery. Learn all about surgery and the guidelines your doctor will be following for your treatment.Support the showGet show notes and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org

A dad-of-two who can't work following major surgery to remove a tumour says he has been unable to secure any financial help during his six-month recovery.The 40-year-old was first told he had cancer last July and applied for personal independence payments before his surgery but says he was told he was not eligible.Also in today's podcast, a drink-driver who "catastrophically ruined" a teenage girl's life after causing a horror crash has been locked up. The 21-year-old plumber was double the legal limit from downing four pints in a pub when his car careered into the path of a another vehicle in Deal. As Kent families head out to enjoy the sunshine, there's a warning from Kent Wildlife Trust not to let dogs off their leads around livestock.It's after rangers found a goat that had been killed in a suspected attack at a nature reserve near Canterbury.A businessman says he has built a “one-stop shop” for residents of a new-build development including a health centre and dentist.800 people in Castle Hill, part of Ebbsfleet Garden City, were asked what was missing from their community – that's when Sam Bott came up with the idea of The Prep Rooms.And we've got reaction from Whitstable Town's FA Vase semi-final now they're off to Wembley for the first time in the club's history. While the match ended in a draw they're through to the final on aggregate. 

Dr. Constanze Rayhrer, breast surgeon with Franciscan Health, discusses breast cancer surgery options such as lumpectomy and mastectomy, and explains why a patient might consider each.

Rev. Jodi of Self-Cell Care, Suson Essentials, welcomes Ryan Encinas, a holistic RN, specializes in metabolic health and mindset optimization. Utilizing Nobel Prize-winning Physics, the Bio Scanner, he teaches cellular antioxidant metrics to address nutrient deficiencies. Ryan collaborates with diverse health practitioners to promote prevention and measurable nutrient optimization. With a background in Cancer Surgery at MD Anderson, his experience spans surgical assistance, directorial roles, and Bio Chem, Cell Function, Genetics, and Spirituality. He emphasizes personalized nutrition, lifestyle modifications, and stress management with radical ownership to enhance health span. " We are a system, not symptoms."  All Dis-ease boil down to 2 things. 1. deficiency 2. toxicity Guest: Ryan Encinas, ryan@my-holistic-hub.com , https://holistichub.gethealthyusa.com..., * IG:   / _holistic_hub   FB:   / 18akl2uoom   in:   / ryan-encinas-holistihub   Host: Rev. Jodi Suson Jodi@SusonEssentials.com ; www.susonessentials.com, YouTube    / @susonessentials   Facebook   / susonessentials   Twitter   / susonessentials   Instagram    / susonessentials    

Listen to the final episode of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today®. In this episode, Dr. Melissa Hogg, a member of the Women in Cancer Surgery Committee, and Dr. Tari King, Chief of Breast Surgery at Dana-Farber Brigham Cancer Center discuss organizational fund flow and share insights on managing financial matters in the field.

In this episode of SurgOnc Today®, Dr. Patricio Polanco, from the University of Texas Southwestern and Vice-chair of the SSO HPB disease site working group, and Dr. Sandra DiBrito, from Albany Medical College and member of the HPB disease site working group, are joined by Dr. Marc Besselink, of Amsterdam University Medical Center, and Dr. Amer Zureikat, of University of Pittsburgh. This is the second episode in our Minimally Invasive Techniques in Hepatobiliary Surgery Series. We will focus today on minimally invasive pancreas surgery.

In this episode of SurgOnc Today®, Dr. Patricio Polanco from the University of Texas Southwestern and Vice-chair of the SSO HPB disease site working group and Dr. Sandra DiBrito from Albany Medical College and member of the HPB disease site working group are joined by Dr. Asmund Fretland of the University of Oslo and Dr. Laleh Melstrom of City of Hope. This is the first episode in our Minimally Invasive Techniques in Hepatobiliary Surgery Series. We will focus on the minimally invasive surgery techniques on the liver, discussing patient selection, benefits of the MIS approach, potential drawbacks, and the impact of this approach on patient outcomes.

Listen to Part 3 of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today®. In this episode, Women in Cancer Surgery Committee Members, Drs. Anita Mamtani and Erika Schmitz, are joined by Bryan Neel, Lead Staff Financial Planner for Physicians and Executives at the Mayo Clinic in Florida. Together, they'll discuss financial literacy as it relates to insurance, disability, retirement, and more.

Listen to Part 2 of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today®. In this episode, Women in Cancer Surgery Committee Members, Drs. Maggie DiNome and Andrea Barrio, are joined by Karen Price, Senior Revenue Manager - Department of Surgery, at Duke University. They will focus on an in-depth discussion of coding strategies and tips to improve billing, understand the use of relevant modifiers, and the use of time-based billing.

Join us for Part 1 of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today. In this episode, Chair of the Women in Cancer Surgery Committee, Dr. Sarah McLaughlin, and Committee Member, Dr. Aimee Crago, will be joined by Alice Rigdon, Chief Financial Officer at the Mayo Clinic in Florida to provide a primer on financial literacy as it relates to department, division, and institutional finances. It will provide a broad framework of common terms and associated financial definitions.

Imagine if a single blood test could tell clinicians in real time how successful a cancer surgery has been. A recent study from the University of Brasília, published in Oncotarget, suggests that such an approach might soon be possible. By tracking changes in cell-free DNA (cfDNA) levels before, during, and after colorectal cancer (CRC) surgery, researchers have found a potential new way to monitor tumor removal and predict patient outcomes. Cell-Free DNA and Colorectal Cancer Surgery Cell-free DNA consists of tiny fragments of genetic material that are released into the bloodstream when cells break down. In healthy individuals, these fragments come from normal cell turnover, but in cancer patients, some of this DNA originates from tumor cells. cfDNA detection has been used to track cancer progression and treatment response in diseases like lung, breast, and CRC. What had not been investigated until now was how cfDNA levels fluctuate during cancer surgery itself. Since surgery is the primary treatment for CRC, understanding how cfDNA levels change during surgical intervention could provide valuable insights into whether the tumor has been fully removed and how the patient's body reacts to the procedure. The Study: Measuring Cell-Free DNA in Real-Time In the study, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery,” led by first author Mailson Alves Lopes and corresponding author Fabio Pittella-Silva, scientists analyzed ​​blood plasma samples from 30 CRC patients at three critical time points—before, during, and after surgery. Using highly sensitive genetic tests, they measured changes in cfDNA concentration to determine whether surgery had a direct impact on its release. The goal was to check whether cfDNA could serve as a biomarker for evaluating surgical effectiveness and predicting the probability of cancer recurrence. Full blog - https://www.oncotarget.org/2025/02/26/how-a-simple-blood-test-could-predict-colorectal-cancer-surgery-success/ Paper DOI - https://doi.org/10.18632/oncotarget.28681 Correspondence to - Fabio Pittella-Silva - pittella@unb.br Video short - https://www.youtube.com/watch?v=jC5_xqIrbtA Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28681 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, colorectal cancer, cfDNA, surgery About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

BUFFALO, NY - January 27, 2025 – A new #research paper was #published in Oncotarget's Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery." Researchers from the University of Brasília investigated how cell-free DNA (cfDNA) levels in the blood change before, during, and after colorectal cancer surgery. The study found that cfDNA levels increase significantly during and after surgery. The findings suggest that cfDNA could help clinicians evaluate surgery effectiveness and monitor patient outcomes. cfDNA consists of small DNA fragments released into the bloodstream when cells die and break apart. In healthy individuals, cfDNA usually comes from normal cell turnover, while in cancer patients, some of it originates from tumor cells. Measuring cfDNA levels offers valuable insights into a patient's condition and is already being used to track disease progression and treatment response in cancers such as lung, breast, and colorectal cancer. Colorectal cancer is one of the most common cancers worldwide, affecting millions of people each year. Surgery is often the primary treatment, but up to 50% of patients experience cancer recurrence afterward. In this study, the research team, led by first author Mailson Alves Lopes and corresponding author Fabio Pittella-Silva, analyzed blood samples from 30 patients at three key time points: before, during, and after surgery. It was found that cfDNA levels increased nearly threefold during surgery and doubled after surgery compared to pre-surgery levels. The increases were even higher in individuals over 60, those with preexisting conditions such as diabetes or heart disease, and patients with elevated levels of carcinoembryonic antigen (CEA), a common cancer marker. Patients with the highest cfDNA levels were those with larger or more aggressive tumors, likely due to greater tissue damage during surgery. Additionally, longer surgeries were linked to higher cfDNA levels. “[...]we observed that cfDNA concentration may rise in correlation with the duration of the surgery, highlighting its potential as a marker of surgical quality.” These findings suggest that cfDNA could be a valuable, non-invasive biomarker for clinicians to monitor colorectal cancer patients. Tracking cfDNA levels may help better evaluate surgical outcomes and determine whether patients require closer follow-up care. While these findings are promising, further research is needed to standardize cfDNA testing and validate its usefulness. Larger studies could help establish cfDNA testing as a reliable tool for cancer care and postoperative monitoring, with the potential to become a routine part of clinical practice in the future. DOI - https://doi.org/10.18632/oncotarget.28681 Correspondence to - Fabio Pittella-Silva - pittella@unb.br Video short - https://www.youtube.com/watch?v=jC5_xqIrbtA About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Dr. Brooke Britton, veterinary oncologist, answers a listener's question about their dog's large mammary tumor and whether waiting a week for surgery is too long. Dr. Britton discusses the complexities of surgery for large tumors, alternative treatment options, and ways to manage your dog's comfort while waiting for surgery. Episode Highlights Listener question from Gio about a ruptured mammary tumor in his dog. Expert advice on surgical timing and tumor management. Practical tips for improving your dog's quality of life while awaiting treatment. Key Takeaways A week may be a reasonable timeframe for surgery if the tumor appears stable. Some tumors deemed "too large" may still be partially removed to improve quality of life. Consult a veterinary surgeon for advanced cases and second opinions. Manage your dog's comfort with appropriate medications, coverings, and e-collars. Your Voice Matters! If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question. Related Videos: https://www.youtube.com/watch?v=7n8I67ejtRo Related Links: A comprehensive guide to surgery for your dog: https://www.dogcancer.com/articles/diagnosis-and-medical-procedures/your-dog-surgery-guide/ An overview of breast cancer in dogs: https://www.dogcancer.com/articles/types-of-dog-cancer/mammary-tumors-in-dogs/ Chapters: 00:00 Introduction 00:15 Listener Call: Gio's Question 02:00 Is a Week Too Long to Wait? 03:30 What If the Tumor Is "Too Large"? 05:15 Specialist vs. General Practitioner Vets 09:00 Managing Your Dog's Comfort 13:15 Why Surgery Is Usually the Best Option 14:00 Closing Thoughts   Get to know Dr. Brooke Britton: https://www.dogcancer.com/people/brooke-britton-dvm-dacvim-oncology/ For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/ Learn more about your ad choices. Visit megaphone.fm/adchoices

'Out of Control': Insurance Giant UnitedHealth Calls in Middle of Cancer Surgery to Question Necessity. FINALLY- The myth of a failed Jimmy Carter presidency was imploded with this eulogy. Subscribe to our Newsletter: https://politicsdoneright.com/newsletter Purchase our Books: As I See It: https://amzn.to/3XpvW5o How To Make America Utopia: https://amzn.to/3VKVFnG It's Worth It: https://amzn.to/3VFByXP Lose Weight And Be Fit Now: https://amzn.to/3xiQK3K Tribulations of an Afro-Latino Caribbean man: https://amzn.to/4c09rbE

Join me for my next live video in the app* FINALLY- The myth of a failed Jimmy Carter presidency was imploded with this eulogy: Former White House Domestic Affairs advisor Stuart Eizenstat laid waste to the fallacy that President Jimmy Carter had a less than effective presidency. In fact, it was one of the most impactful. [More]* ‘Out of Control': Insurance Giant UnitedHealth Calls in Middle of Cancer Surgery to Question Necessity: Dr. Elisabeth Potter shared “another horror story from a doctor dealing with United Healthcare's terrible authorization process.” [More] To hear more, visit egberto.substack.com

Interview with Michael Archer, DO

Love the episode? Send us a text!Breast cancer is a deeply personal journey. As the landscape of breast cancer treatment evolves, understanding the surgical options available becomes crucial for patients navigating this challenging experience. In this episode, we speak with Dr. Yolanda Tamero, a breast surgical oncologist, who provides invaluable insights into the various surgical interventions available for those diagnosed with breast cancer. We talk about the different types of breast surgeries, the roles of various medical professionals involved, and the considerations that we should keep in mind when making decisions about our surgical treatment options. Support the show

In today's episode host Brette Borow and Dr. Marla Anderson, Medical Director of Surgical Breast Oncology Mission Hospital California are talking about breast cancer and breast cancer surgery. In this episode you will hear about the types of breast cancer, screening and treatment options and what to expect with both.

Jase refuses to believe in the merits of pedicures, even though Al sings their praises, and Lisa returns for an update on her second reconstructive surgery post-breast cancer. Jase compares the fake news of man-made gods to the good news of the gospel, and Jesus was the prototype for God becoming man as well as God living among men. Lisa relates her tale of desperation that led her to Christ and how she realized she'd made her husband the lord of her life instead of Jesus.  In this episode: Colossians 1; Colossians 2; 1 Corinthians 8, verses 1-6 “Unashamed” episode 979 is sponsored by: https://preborn.com/unashamed — SAVE babies with your tax-deductible donation today! https://alpinegold.com — Get FREE shipping on orders over $200 with code UNASHAMED. https://BlazeUnlimited.com/Unashamed — Claim your spot & join the mission to defend free speech & uphold the American way of life! https://philmerch.com — Get your “Unashamed” mugs, shirts, hats & hoodies! -- Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we speak with Dr. Jean Bao, Clinical Assistant Professor of Surgery at Stanford University School of Medicine. We will explore prevalent misconceptions about breast cancer encountered in clinical practice, as well as the decision-making processes involved in managing benign masses and high-risk patients. Additionally, we will discuss innovative diagnostic technologies for at-risk individuals, the pathology of dense breast tissue, and new imaging techniques. We will also examine when to opt for a lumpectomy versus a double mastectomy, prophylactic mastectomy, skin and nipple-sparing mastectomies, and oncoplastic surgeries, focusing on their impact on patient outcomes and quality of life. Lastly, we will review nodal staging strategies for breast cancer and delve into Dr. Bao's research on fertility issues faced by young women with breast cancer. Read Transcript CME Information: https://stanford.cloud-cme.com/medcastepisode90 Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=3086  

Kennedy is back  after having surgery to remove "Melvin" last Thursday. Find out how she is doing and what's next on her journey back to health.

Kennedy is back  after having surgery to remove "Melvin" last Thursday. Find out how she is doing and what's next on her journey back to health.

Kennedy is back! Find out all the details about how she is feeling after having "Melvin" removed and what's next on her cancer journey. We also play Can't Beat Kennedy and 8 Bit Hits to give away some Post Malone tickets!

Kennedy's Cancer Surgery is Tomorrow, Jason Santos Blind Taste Test, Clear the List, Good Vibe Tribe

Kennedy has a big day tomorrow and she tells us how she's feeling! 

In this episode, Tom Varghese, MD, FACS is joined by Calista M Harbaugh, MD, MSc, from the University of Michigan. They discuss Dr Harbaugh's recent study, “Association of National Accreditation Program for Rectal Cancer Accreditation with Outcomes after Rectal Cancer Surgery,” in which the authors found that hospitals accredited by the National Accreditation Program for Rectal Cancer are associated with lower short- and long-term morbidity and mortality, but few programs achieve accreditation status.   Disclosure Information: Drs Varghese and Harbaugh have nothing to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

Dr. Rick Greene discusses with Dr. Timothy Pawlik and Dr. Diamantis Tsilimigras the assessment of perioperative mortality and serious complications among patients undergoing complex cancer surgery by surgical oncology fellowship graduates across different career stages. Dr. Pawlik and Dr. Tsilimigras are co-authors of "Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career Stages."

Marcus Malek, MD, FACS, FAAP, director of Pediatric Surgical Oncology at UPMC Children's Hospital of Pittsburgh discusses the technology gap in the operating room that inspired his research to improve cancer surgery imaging.

Welcome back to our weekend Cabral HouseCall shows! This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track! Check out today's questions:    Vikki: My son had kawasaki disease at 5yo. In hospital for week, got 2 IVIG treatments & high doses aspirin. Heart always looked good. Hes 16 & has been dealing w mild hearing loss& tinnitus, what can he do to lessen ringing or reverse? Assuming it was caused by the disease. Covid made it worse (no shot). Dizzy when it's at its worst. Avoids loud places, like movie theatre/church. Tried hearing aids but says didn't help. Healthy otherwise. Also what do you know about Kawasaki& future complications? TY   Fiona: I have used your products to correct my autoimmune issues, thank you so much for helping me. My daughter is fighting a EBV infection and is so exhausted every day. She has just had an IV vitamin C treatment. She also has Enterococus Avium detected in stool. Bifidobacterium bifidium and breve, Lactobacillus plantarum, casei and acidophlis have low readings. What is the best protocol for her to follow please   Jay: Hi Dr. Cabral I want to thank you and your team for all the work you do - it has been life changing for both me and my clients. I ran the big 5 did FM 21 detox, HMD, Ultimate sleep, Estrogen detox, and in the CBO protocol. I am wondering if you could tell me when I could retest to see improvement (looking to concieve - want to make sure everything is optimized). For reference I had low DHEA, high cortisol, estrogen dominance, + mercury, + aluminum candida, and oxalic acid.   Patricia: Dear Dr. Cabral, thank you for all the information and knowledge you share, it has really made a difference in my life. This question is related to my father, he is 84 years old and recently diagnosed with skin cancer on different areas on his face,we believe it was caused to sun exposure and or chemicals due to his job when younger as a Petroleum Engineer working in the field. He has molds in his face and his back, some of those cancerous. One was recently removed from his tear duct cancerous. He is scheduled to have surgery soon for all the others found. Is there any recommendation you can give me on things that he can do before and after the procedure related to diet and supplements that can help him heal faster and prevent recurrencies? I value so much your opinion. Thank you so much   Fernanda: I bought an EquiLife heavy metal detox kit for me and my husband and I just did your regular detox course online. Now I am wondering how these 2 compare. We don't want to lose weight as we are overall healthy already. We have completed three 5-day fasts using another product (Prolon) recently. How does a 5-day fast compare to EquiLife 7 day detox as far as removing toxins go? Will the removal of toxins in a 5-day water only or Prolon fast be compromised because there may not be enough amino acids to aid the phase 2 detox pathways? Should I do the regular detox before the heavy metal one? Please feel free to email me directly if that is not a question that you would like to answer on the podcast. FYI: I am also currently an IHP1 student and I bought 8 of the books you recommended so far.   Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/3032 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!